At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
YB Yuanbao Inc.
Market Closed 10-09 16:00:00 EDT
12.11
-0.13
-1.10%
High12.24Low11.96Vol26.24K
Open12.24D1 Closing12.24Amplitude2.33%
Mkt Cap557.80MTradable Cap99.27MTotal Shares46.08M
T/O316.41KT/O Rate0.32%Tradable Shares8.20M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Hashrate Hurdle Rises 4.7%: Bitcoin Must Clear $82,900 to Preserve Miner Margins
Stock News  ·  09-15
Hashrate Hurdle Rises 4.7%: Bitcoin Must Clear $82,900 to Preserve Miner Margins
Yuanbao, Inc. Earnings Call Highlights AI-Led Growth
TIPRANKS  ·  09-12
Yuanbao, Inc. Earnings Call Highlights AI-Led Growth
Yuanbao Q2 FY26 Net Income Rises 35.6% to RMB 413.2 Million; Revenue Increases 30.1% to RMB 1.39 Billion
Reuters  ·  09-10
Yuanbao Q2 FY26 Net Income Rises 35.6% to RMB 413.2 Million; Revenue Increases 30.1% to RMB 1.39 Billion
Yuanbao Q2 Adj. EPS $1.32 Up From $0.97 YoY, Sales $205.182M Up From $149.356M YoY
Benzinga Earnings  ·  09-10
Yuanbao Q2 Adj. EPS $1.32 Up From $0.97 YoY, Sales $205.182M Up From $149.356M YoY
Yuanbao - Q2 2026 Total Revenues up 30.1% to Rmb1,392.2 Mln (us$205.2 Mln)
THOMSON REUTERS  ·  09-10
Yuanbao - Q2 2026 Total Revenues up 30.1% to Rmb1,392.2 Mln (us$205.2 Mln)
Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results
THOMSON REUTERS  ·  09-10
Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results
Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest
TIPRANKS  ·  09-05
Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest
Yuanbao to Report Q2 2026 Results, Host Earnings Call
Reuters  ·  09-03
Yuanbao to Report Q2 2026 Results, Host Earnings Call
Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026
GlobeNewswire  ·  09-03
Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026
YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table
Dow Jones  ·  08-28
YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table
Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-13
Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Yarrow Bioscience initiated with a Buy at TD Cowen
TIPRANKS  ·  07-28
Yarrow Bioscience initiated with a Buy at TD Cowen
Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101
Deep News  ·  07-27
Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101
Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101
MT Newswires Live  ·  07-27
Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101
Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease
Dow Jones  ·  07-27
Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease
Stocks Ex-dividend July 2
Dow Jones  ·  07-01
Stocks Ex-dividend July 2
Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge
TIPRANKS  ·  06-12
Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge
Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance
TIPRANKS  ·  06-10
Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance
Yuanbao to remain focused on high-quality revenue growth
TIPRANKS  ·  06-10
Yuanbao to remain focused on high-quality revenue growth
Yuanbao announces $15M share repurchase program
TIPRANKS  ·  06-10
Yuanbao announces $15M share repurchase program

Introduction

Company Name.
Yuanbao Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Yuanbao, Inc. operates as a holding company, which provides online insurance distribution and services. Its products include million medical insurance, comprehensive accident insurance, and major disease insurance. The company was founded by Rui Fang in December 2019 and is headquartered in Beijing, China.
Issue price:
--